Malgorzata A. Walicka

Array ( [id] => 9211606 [patent_doc_number] => 20140010783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'ANTIVIRAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/933468 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52292 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9206062 [patent_doc_number] => 20140005239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Compositions and Methods for Treating or Preventing Pneumovirus Infection and Associated Diseases' [patent_app_type] => utility [patent_app_number] => 13/931201 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 18013 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11389522 [patent_doc_number] => 09550757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Nuclear transport modulators and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/931372 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 76259 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408840 [patent_doc_number] => 09556132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Tetrazole derivatives and their use as potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 14/411314 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9259 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14411314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408840 [patent_doc_number] => 09556132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Tetrazole derivatives and their use as potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 14/411314 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9259 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14411314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10428221 [patent_doc_number] => 20150313233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'ANTIMICROBIAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/410559 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10186 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9477865 [patent_doc_number] => 20140135329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'Pyridine and Pyrazine derivative for the Treatment of CF' [patent_app_type] => utility [patent_app_number] => 13/923349 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39505 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10541733 [patent_doc_number] => 09266844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-23 [patent_title] => 'Suppression of SARS replication by SARS helicase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/919951 [patent_app_country] => US [patent_app_date] => 2013-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9621083 [patent_doc_number] => 08791256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Pyrrolopyridine derivatives and their use as CRTH2 antagonists' [patent_app_type] => utility [patent_app_number] => 13/910769 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25218 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13910769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082197 [patent_doc_number] => 20130267727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'Process for Preparing Dialkyl Carbonate and Diol Products' [patent_app_type] => utility [patent_app_number] => 13/906786 [patent_app_country] => US [patent_app_date] => 2013-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6851 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13906786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202839 [patent_doc_number] => 20150087827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'METHOD FOR THE PREPARATION OF TRIAZOLE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/399929 [patent_app_country] => US [patent_app_date] => 2013-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13593 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13207185 [patent_doc_number] => 10117943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer [patent_app_type] => utility [patent_app_number] => 14/888779 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 24 [patent_no_of_words] => 32787 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055483 [patent_doc_number] => 20130253197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'FUSED BICYCLIC KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/873353 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82555 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13873353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10241526 [patent_doc_number] => 20150126521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'Oral Formulation' [patent_app_type] => utility [patent_app_number] => 14/397683 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5163 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10593468 [patent_doc_number] => 09314539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Nanosphere-histone acetyltransferase (HAT) activator composition, process and methods thereof' [patent_app_type] => utility [patent_app_number] => 14/397561 [patent_app_country] => US [patent_app_date] => 2013-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 31 [patent_no_of_words] => 10166 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895975 [patent_doc_number] => 20150051171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES' [patent_app_type] => utility [patent_app_number] => 14/386111 [patent_app_country] => US [patent_app_date] => 2013-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 233112 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534753 [patent_doc_number] => 09260371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Compositions and methods for modification of biomolecules' [patent_app_type] => utility [patent_app_number] => 13/868444 [patent_app_country] => US [patent_app_date] => 2013-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 41641 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094918 [patent_doc_number] => 20130274230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => '(2-UREIDOACETAMIDO)ALKYL DERIVATIVES AS FORMYL PEPTIDE RECEPTOR 2 MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/863934 [patent_app_country] => US [patent_app_date] => 2013-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15504 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406562 [patent_doc_number] => 20150291570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides' [patent_app_type] => utility [patent_app_number] => 14/396877 [patent_app_country] => US [patent_app_date] => 2013-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33476 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401794 [patent_doc_number] => 08691846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Piperidine sulphonamide derivatives' [patent_app_type] => utility [patent_app_number] => 13/855470 [patent_app_country] => US [patent_app_date] => 2013-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6850 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855470 [rel_patent_id] =>[rel_patent_doc_number] =>)